Literature DB >> 4053052

Secreted phosphoprotein markers for neoplastic transformation of human epithelial and fibroblastic cells.

D R Senger, C A Perruzzi.   

Abstract

A wide variety of rodent tumor cells of both fibroblastic and epithelial origins secrete a major transformation-related phosphoprotein with a molecular weight of approximately 62,000. Tumorigenic cells, regardless of the transforming agent, secrete 10-fold or more of this 32P-labeled protein as compared with their nontumorigenic counterparts. In this study we have extended these previous findings to tumorigenic human cells of diverse origins (both sarcomas and carcinomas). Metabolic labeling of cells with [32P]orthophosphate and immunoprecipitation with antibody specifically directed against the rat transformation-dependent secreted phosphoprotein have been used to identify antigenically related human phosphoproteins (Mr 66,000-69,000). Of the 14 human cell lines examined, all 8 of the lethal tumorigenic cell populations secreted these phosphoproteins either in continuous culture or as fresh explants from nude mice while the six nonmalignant cell lines did not (tumorigenicity in all cases was assayed in nude mice). Included in our study were three tumorigenic human cell lines (two sarcomas, one carcinoma), each with a matched, nontumorigenic control. The very close correlation between secretion of these phosphoproteins and the tumor cell phenotype of both rodents and humans raises the possibility that they may be important for tumor growth in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4053052

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Short-term effect of combined therapy with Jinlong Capsule and transcatheter arterial chemoembolization on patients with primary hepatic carcinoma and its influence on serum osteopontin expression.

Authors:  Guo-lin Wu; Li Zhang; Tian-yi Li; Jiu Chen; Guo-you Yu; Jian-ping Li
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

2.  Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.

Authors:  Nermeen S Youssef; Wesam M Osman
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 3.  Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

Authors:  A O'Regan; J S Berman
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

4.  T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen.

Authors:  D R Senger; C A Perruzzi; I U Ali
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines down-regulated for OPN expression by a targeted ribozyme.

Authors:  B Feng; E E Rollo; D T Denhardt
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

6.  Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor-beta. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein).

Authors:  J L Wrana; T Kubota; Q Zhang; C M Overall; J E Aubin; W T Butler; J Sodek
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

Review 7.  Physiology of bone: mineral compartment proteins as candidates for environmental perturbation by lead.

Authors:  J J Sauk; M J Somerman
Journal:  Environ Health Perspect       Date:  1991-02       Impact factor: 9.031

8.  Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.

Authors:  Yunzhen Chen; Haichun Liu; Wenliang Wu; Yi Li; Jianmin Li
Journal:  J Exp Clin Cancer Res       Date:  2013-07-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.